EssilorLuxottica stock rating upgraded by Rothschild Redburn on growth potential

Rothschild Redburn upgraded EssilorLuxottica SA to Buy from Neutral, increasing its price target to EUR320.00, citing the company's "unrivalled position" in vision care and strategic expansion into new categories like myopia management and smart glasses. The firm projects margin expansion to 20% by FY2030 and a 14.8% EPS CAGR from FY2025-2028, justifying a premium valuation based on structural advantages and growth potential, despite some anticipated near-term margin pressure.

Analysis

Rothschild Redburn has upgraded EssilorLuxottica SA (EL) to Buy from Neutral, accompanied by a significant price target increase to EUR320.00 from EUR235.00, implying a 21% potential upside. The upgrade is predicated on the company's dominant, or "unrivalled," position in the vision care market, which serves as a foundation for strategic expansion into new, high-growth categories. Key new verticals highlighted include myopia management with its Stellest product, audiology through Nuance, and the smart glasses segment via its partnership with Meta. The research firm projects that these initiatives, leveraging EL's brand and distribution strength, will drive a 14.8% EPS compound annual growth rate from fiscal 2025 to 2028. While acknowledging the potential for near-term margin pressure during this expansion phase, the long-term outlook anticipates margin expansion to 20% by 2030. This combination of structural advantages and new growth vectors is cited as justification for the firm's upgraded forecasts and the stock's premium valuation.

Key Decisions for Investors

• Investors should view this upgrade as a validation of EssilorLuxottica's long-term growth strategy, which hinges on leveraging its core market dominance to penetrate new technology and healthcare verticals.
• Monitor the execution and market adoption of new initiatives in myopia management, audiology, and smart glasses, as these are the primary catalysts for the projected 14.8% EPS CAGR.
• Be prepared for potential near-term margin pressure as the company invests in new categories, but focus on the long-term margin expansion target of 20% by 2030 as a key performance indicator for the thesis.